Patients suffering from the chronic itchy skin condition eczema could soon find relief thanks to an arthritis drug which has also been used to treat Covid Last week, the NHS approved baricitinib for the treatment of moderate to severe eczema which affects more than one million Britons. The condition, which is characterised by painful skin, redness and intense itching is a common childhood condition, but for around one in 40 people in the UK it continues into adulthood. Bizarre as it sounds, this is a rare, debilitating neurological condition that affects roughly two in every million people. Spasms can be so forceful that they result in bone fractures. It is more common in people already suffering with other conditions that affect the immune system, such as diabetes. Now trials have shown the drug is, in addition, highly effective at reducing the debilitating symptoms of eczema, and causes far fewer side effects than medication currently offered on the NHS.
By Lauren Hewett. About a year ago, Alexis Smith received a surprising message via email and Twitter. A global skincare brand wanted to interview her by phone after finding her on Instagram eczemalove , and she promptly responded to that request. Next, the brand representative asked Smith to tell her story in a short video, and once again, she followed through.
Right or Mr. Right Now, there are plenty of dating websites and apps to find him. For people with certain health conditions or concerns, it can be hard to meet new people on traditional sites like OkCupid and Tinder because they might worry about how soon to tell their potential partners about their diagnosis. People with autism may be worried about the perceived stigma surrounding their diagnosis or just the awkwardness of telling someone about it on a non-autistic dating site, Cantu told Buzzfeed News.